Investment Considerations Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology. The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies … Continue reading “Processa Pharmaceuticals Inc. (NASDAQ: PCSA)”
| Symbol | Release | Time | Source |
|---|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} | {{ release.source }} |
SmallCapRelations is part of the IBN (InvestorBrandNetwork).